Common Contracts

CLOSING AGREEMENT

Closing Agreement • September 19th, 2023 • Bioxytran, Inc • Pharmaceutical preparations

• Contract Type
  Closing Agreement
• Filed
  September 19th, 2023
• Company
  Bioxytran, Inc
• Industry
  Pharmaceutical preparations

This Closing Agreement (the “Agreement”), dated as of September 18, 2023 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor”).

AMENDED CLOSING AGREEMENT

Closing Agreement • August 3rd, 2023 • Bioxytran, Inc • Pharmaceutical preparations

• Contract Type
  Closing Agreement
• Filed
  August 3rd, 2023
• Company
  Bioxytran, Inc
• Industry
  Pharmaceutical preparations

This Amended Closing Agreement (the “Agreement”), dated as of August 1, 2023 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor”).

CLOSING AGREEMENT

Closing Agreement • June 12th, 2023 • Bioxytran, Inc • Pharmaceutical preparations

• Contract Type
  Closing Agreement
• Filed
  June 12th, 2023
• Company
  Bioxytran, Inc
• Industry
  Pharmaceutical preparations

This Closing Agreement (the “Agreement”), dated as of June 6, 2023 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor”).